WebApr 11, 2024 · 12 analysts have issued 1-year target prices for BioNTech's stock. Their BNTX share price forecasts range from $128.00 to $260.00. On average, they predict the … WebApr 12, 2024 · BioNTech Stock Performance. NASDAQ:BNTX opened at $126.34 on Monday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 7.28 and a current ratio of 7.43. BioNTech has a fifty-two ...
BNTX BioNTech SE ADR Stock Price & News - WSJ
WebFounded. 2008. BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, … WebApr 11, 2024 · According to the issued ratings of 13 analysts in the last year, the consensus rating for BioNTech stock is Hold based on the current 7 hold ratings and 6 buy ratings for BNTX. The average twelve-month price prediction for BioNTech is $178.50 with a high price target of $260.00 and a low price target of $130.00. ev battery plant in oklahoma
JP Morgan Maintains BioNTech SE (BNTX) Neutral …
WebBNTX: BioNTech SE - Stock Price, Quote and News - CNBC BioNTech SE BNTX:NASDAQ EXPORT WATCHLIST + LIVE SQUAWK BOX RT Quote Last NYSE … WebApr 10, 2024 · 0. 0. In the last 3 months, 12 analysts have offered 12-month price targets for BioNTech. The company has an average price target of $169.33 with a high of $216.00 and a low of $128.00. Below is a ... WebMar 2, 2024 · Biopharmaceutical New Technologies or BioNTech ( NASDAQ: BNTX) is a large ($31 billion market cap) immunotherapy company. They are developing cancer product candidates (Figure 1) but known mostly ... first community bank of east tennessee